scispace - formally typeset
R

Ricardo P. J. Budde

Researcher at Utrecht University

Publications -  109
Citations -  2476

Ricardo P. J. Budde is an academic researcher from Utrecht University. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 24, co-authored 85 publications receiving 2143 citations. Previous affiliations of Ricardo P. J. Budde include Gelre Hospitals & Erasmus University Rotterdam.

Papers
More filters
Journal ArticleDOI

Iterative reconstruction techniques for computed tomography Part 1: technical principles.

TL;DR: Iterative reconstruction technology for CT is presented in non-mathematical terms and IR can improve image quality in routine-dose CT and lower the radiation dose, and IR's disadvantages include longer computation and blotchy appearance of some images.
Journal ArticleDOI

Iterative reconstruction techniques for computed tomography part 2: initial results in dose reduction and image quality

TL;DR: Benefits of IR include improved subjective and objective image quality as well as radiation dose reduction while preserving image quality and future studies need to address the value of IR in ultra-low-dose CT with clinically relevant endpoints.
Journal ArticleDOI

Comparison of multidetector-row computed tomography to echocardiography and fluoroscopy for evaluation of patients with mechanical prosthetic valve obstruction.

TL;DR: Initial experience demonstrates that multidetector-row computed tomography can identify causes of prosthetic valve obstruction that constitute indications for surgery but are missed at echocardiography or fluoroscopy.
Journal ArticleDOI

Aortic root dimension changes during systole and diastole: evaluation with ECG-gated multidetector row computed tomography

TL;DR: This study demonstrated a significant individual dynamic change in the dimensions of the aortic root, independent of gender, age, height and weight, which is highly unpredictable.
Journal ArticleDOI

First-in-man experience with a new embolic deflection device in transcatheter aortic valve interventions.

TL;DR: In this first-in-man experience, the feasibility of a new embolic deflection device is demonstrated and larger randomised, prospective studies are required to confirm these findings and prove safety and efficacy by reducing the incidence of cerebral embolism and stroke after TAVI.